药师帮：第三季度收入同比增长15%，致力于推出高质量自有品牌产品

Core Insights - The company announced a 15% year-on-year revenue growth for the three months ending September 30, 2025, surpassing the revenue growth rate of the first half of 2025 compared to the first half of 2024 [1] - The group's flagship business, including its proprietary brand operations, saw a transaction volume increase of over 120% year-on-year, with proprietary brand transactions growing over 350% in the same period [1] - The flagship business is a key strategic initiative under the "Upward Mobility" plan, significantly contributing to profitability [1] - The company is strategically expanding its proprietary brand product offerings to meet diverse market demands and drive continuous business growth [1]